Evidence map›Paper›PMID 31492140›Full record

ArticleBMC complementary and alternative medicine2019

Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae).

Winnie Mozirandi, Dexter Tagwireyi, Stanley Mukanganyama

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 43 citations in OpenAlex.

  1. Establishment of Callus Cultures fromMolecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Plant-Origin Components: New Players to Combat Antibiotic Resistance inInternational journal of molecular sciences · 2024
    Review
  4. Article
  5. Colistin potentiation in multidrug-resistantFrontiers in microbiology · 2022
    Article
  6. Review
  7. Plant Derived Natural Products againstMolecules (Basel, Switzerland) · 2020
    Review
  8. Susceptibility of MatureBioMed research international · 2020
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Winnie MozirandiDepartment of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt. Pleasant, Harare, Zimbabwe.
Dexter TagwireyiSchool of Pharmacy, College of Health Sciences, University of Zimbabwe, P.O. Box A178, Avondale, Harare, Zimbabwe.
Stanley MukanganyamaDepartment of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt. Pleasant, Harare, Zimbabwe. smukanganyama@medic.uz.ac.zw.ORCID http://orcid.org/0000-0001-6071-6439
University of Zimbabwe · ZW

Funding

Centre for Emerging and Neglected Diseasess Unversity of ZimbabweInternational Foundation for Science IFS F/3413-03FInternationl Science Programmes IPICS-ZIM01
6 · The paper itself

Abstract

backgroundBacteria have developed resistance to most of the current antibiotics. There is evidence suggesting that plant-derived compounds have a potential for interacting with biological processes. One of the plants commonly used in African ethnomedicine is Vernonia adoensis from the Asteraceae family. The leaves of the plant have been reported to have antimicrobial activity. Hence, the aim of this study was to isolate the bioactive compounds from the leaf extract and evaluate their antibacterial activity on Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa. In addition, the effect of the isolated compound on biofilms of P. aeruginosa was determined.

methodsIsolation of phytochemicals from the leaves of V. adoensis was done using column chromatography. Preparative TLC was used to further isolate mixed compounds in the fractions. Nuclear magnetic resonance spectroscopy and mass spectrometry was used to identify the isolated pure compounds. The broth microdilution assay was carried out to evaluate the antibacterial activity of the isolated compound on P. aeruginosa, S. aureus and K. pneumoniae. Crystal violet staining technique was used to evaluate the effect of the isolated compound on biofilms of P. aeruginosa.

resultsThe compound isolated from V. adoensis was identified as chondrillasterol. Chondrillasterol exhibited 25, 38 and 65% inhibition of growth on S. aureus, K. pneumoniae and P. aeruginosa respectively. At 1.6 μg/mL chondrillasterol completely disrupted mature biofilm of P. aeruginosa while at 100 μg/mL the compound completely inhibited formation of biofilms of the bacteria.

conclusionChondrillasterol isolated from V. adoensis has antibacterial properties against S. aureus, K. pneumoniae and P. aeruginosa. The compound also has biofilm inhibition and disruption activity against P. aeruginosa biofilms. Thus, the active phytochemical could be a useful template for the development of new antimicrobial agents with both antibacterial and antibiofilm activity.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsBiofilmsDrug Evaluation, PreclinicalHumansMicrobial Sensitivity TestsPlant ExtractsPseudomonas aeruginosaStaphylococcus aureusSteroidsVernoniaAnti-Bacterial AgentschondrillasterolPlant ExtractsSteroidsAntibacterialBiofilmsChondrillasterolVernonia adoensis

Identifiers

PMID31492140
PMCPMC6731578
OpenAlexW2971929062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.